Biosynex SA (ENXTPA: ALBIO)
Health Care · Health Care Equipment & Supplies · FR
€0.91
-1.51% today · -21.5% 1Y
Biosynex SA (ENXTPA: ALBIO) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $19.93M and employs 397 people.
Over the last twelve months the share price has lost 21.5%, trading between 0.46 and 1.57.
Tweenvest scores Biosynex SA across four factors: quality 55/100, value 65/100, growth 0/100. Its strongest factor is value.
ALBIO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $19.93M
- Revenue (TTM)
- $111.77M
- P/E
- —
- EPS
- -3.16
- Dividend yield
- —
- Beta (5Y)
- 0.83
- 52-week high
- €1.57
- 52-week low
- €0.46
- Avg volume (3M)
- —
- Shares outstanding
- 18.43M
- Employees
- 397
- Next earnings
- —
About Biosynex SA
Biosynex S.A. specializes in the development, manufacture, and worldwide distribution of rapid diagnostic solutions. Their extensive product line includes a variety of quick diagnostic assays, immunoblots, molecular biology tools, and point-of-care devices. These offerings are vital for screening, diagnosis, and prevention across numerous medical fields, such as bacteriology, parasitology, mycology, virology, biochemistry, oncology, and women's health, alongside specific COVID-19 tests and related instruments. Additionally, Biosynex provides consumer products like self-testing kits, personal health monitoring equipment (including thermometers and blood pressure monitors), and a selection of oral care and medical aid supplies. The company serves a diverse client base, including biological and medical analysis laboratories, hospitals, pharmacies, and large retail outlets like hypermarkets and supermarkets. Founded in 1993, Biosynex S.A. is headquartered in Illkirch-Graffenstaden, France.
- ISIN
- FR0011005933
- Founded
- 2005
- Listed since
- Mar 28, 2011
- Exchange
- Euronext Paris
- Currency
- EUR
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $201.83B | $116.64 | 0.00% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $133.83B | $378.35 | -0.12% |
| Stryker CorporationNYSE: SYK | $126.37B | $330.71 | +0.38% |
| Medtronic plcNYSE: MDT | $119.49B | $93.37 | +0.02% |
| EssilorLuxottica Société anonymeENXTPA: EL | $87.56B | €161.90 | -0.80% |
| Boston Scientific CorporationNYSE: BSX | $73.00B | $49.36 | -2.01% |
| HOYA CorporationTSE: 7741 | $52.38B | ¥24,895.00 | -1.37% |
| Becton, Dickinson and CompanyNYSE: BDX | $52.30B | $191.69 | -0.16% |
Figures last refreshed Aug 18, 2026.